Gainers
- Array BioPharma Inc. ARRY rose 59% to $47.05 in pre-market trading after Pfizer Inc. PFE announced plans to acquire Array BioPharma for $48 per share in cash.
- Daktronics, Inc DAKT rose 19.6% to $7.50 in pre-market trading.
- Orgenesis Inc. ORGS rose 18.9% to $5.10 in pre-market trading after the company disclosed that it has been granted FDA Orphan Drug designation for its Autologous Insulin Producing cells in the treatment of Severe hypoglycemia-prone diabetes resulting from total pancreatectomy.
- Castle Brands Inc ROX rose 17.2% to $0.60 in pre-market trading following Q4 results. Castle Brands posted Q4 earnings of $0.05 per share on sales of $29.89 million.
- Calithera Biosciences, Inc. CALA rose 15.6% to $6.02 in pre-market trading after reporting 'positive' topline results in randomized Phase 2 ENTRATA study of telaglenastat with everolimus in renal cell carcinoma.
- Aclaris Therapeutics, Inc. ACRS rose 15.6% to $5.40 in pre-market trading after reporting positive 6-month results from a Phase 2 open-label clinical trial of ATI-502 topical in patients with androgenetic alopecia.
- Globant S.A. GLOB rose 12.6% to $112.00 in pre-market trading.
- Riot Blockchain, Inc. RIOT rose 11% to $3.03 in pre-market trading after gaining 5.41% on Friday.
- Uniqure NV QURE rose 8.9% to $79.00 in pre-market trading following Bloomberg report that the company is exploring options including a potential sale.
- Antero Midstream Corporation AM gained 8% to $12.50 in pre-market trading after falling 5.24% on Friday.
- OrganiGram Holdings Inc. OGI shares rose 7.7% to $6.75 in pre-market trading after dropping 7.79% on Friday.
- Jazz Pharmaceuticals plc JAZZ rose 6.6% to $139.00 in pre-market trading.
- ReWalk Robotics Ltd. RWLK rose 6.5% to $5.55 in pre-market trading after declining 4.58% on Friday.
- Monster Beverage Corporation MNST shares rose 5.2% to $64.50 in pre-market trading.
- Uxin Limited UXIN rose 5% to $2.12 in pre-market trading after gaining 4.12% on Friday.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Check out these big penny stock gainers and losers
Losers
- VBI Vaccines Inc VBIV shares fell 31.2% to $1.30 in pre-market trading after the company reported results from its Phase 3 Study of Sci-b-vac. The trial met both co-primary endpoints but did not meet its secondary objective of non-inferiority.
- Ampio Pharmaceuticals Inc AMPE fell 21.4% to $0.55 in pre-market trading after reporting a common stock offering.
- Celyad SA CYAD fell 20.3% to $14.75 in pre-market trading.
- Bionano Genomics, Inc. BNGO fell 13.8% to $2.50 in pre-market trading.
- Seanergy Maritime Holdings Corp. SHIP fell 9.2% to $0.59 in pre-market trading. Seanergy Maritime reported a Q4 loss of $3.23 per share, versus a year-ago loss of $1.40 per share. Its sales declined to $16.013 million from $21.322 million.
- Genocea Biosciences, Inc. GNCA fell 6.8% to $4.91 in pre-market trading.
- Bridgeline Digital, Inc. BLIN fell 6.2% to $2.58 in pre-market trading.
- Seadrill Limited SDRL fell 4.2% to $2.99 in pre-market trading after dropping 9.30% on Friday.
- ContraVir Pharmaceuticals, Inc. CTRV fell 3.5% to $8.58 in pre-market trading after declining 12.07% on Friday.
- Endo International plc ENDP fell 3.5% to $3.91 in pre-market trading after dropping 9.40% on Friday.
- NextEra Energy Partners, LP NEP fell 3.3% to $45.02 in pre-market trading.
- India Globalization Capital, Inc. IGC fell 4% to $1.21 in pre-market trading following Q4 results.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasGeneral#PreMarket GainersLosersTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in